Lv3
400 积分 2021-06-01 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
20小时前
待确认
Effective use of BCMA-targeting bispecific T cell-engaging antibody in treatment-refractory LRP4+ myasthenia gravis
7天前
已完结
In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial
8天前
已完结
The Care and Cure of the Leukemias in 2026
15天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
IPNA consensus definitions for clinical trial outcomes in steroid-resistant nephrotic syndrome
1个月前
已完结
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
2个月前
已完结
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
2个月前
已完结
CD7 targeted “off-the-shelf” CAR-T demonstrates robust in vivo expansion and high efficacy in the treatment of patients with relapsed and refractory T cell malignancies
2个月前
已完结
皖公网安备34019202002308
